SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Generation Bio Co. (GBIO) (CIK 0001733294) — Jan 4, 2021

Generation Bio Co. (GBIO) (CIK 0001733294)
Date: Jan. 4, 2021 · CIK: 0001733294 · Accession: 0001193125-21-000980

AI Filing Summary & Sentiment

File numbers found in text: 333-251872

Date
January 4, 2021
Author
GENERATION BIO CO.
Form
CORRESP
Company
Generation Bio Co. (GBIO) (CIK 0001733294)

Letter

Acceleration Request

Generation Bio Co.

301 Binney Street

Cambridge, MA

January 4, 2021

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance, Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attention: Abby Adams

Re: Generation Bio Co.

Registration Statement on Form S-1

File No. 333-251872

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Generation Bio Co. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-251872), as amended, so that it may become effective at 4:10 p.m. Eastern time on January 6, 2021, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request by telephone call to the staff of the U.S. Securities and Exchange Commission. Please contact Stuart M. Falber of Wilmer Cutler Pickering Hale and Dorr LLP, counsel to the Company, at (617) 526-6663, or in his absence, Jeffries Oliver-Li at (617) 526-6786, to provide notice of effectiveness, or if you have any other questions regarding this matter.

[Remainder of Page Intentionally Left Blank]

Very truly yours,
GENERATION BIO CO.

Show Raw Text
CORRESP
1
filename1.htm

Acceleration Request

 Generation Bio Co.

301 Binney Street

 Cambridge, MA
02142

 January 4, 2021

 VIA EDGAR

 U.S. Securities and Exchange Commission

 Division
of Corporation Finance, Office of Life Sciences

 100 F Street, N.E.

Washington, D.C. 20549

 Attention: Abby Adams

Re: Generation Bio Co.

 Registration Statement on Form S-1

 File No. 333-251872

Request for Acceleration

 Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Generation Bio Co. (the “Company”) hereby requests acceleration of
the effective date of its Registration Statement on Form S-1 (File No. 333-251872), as amended, so that it may become effective at 4:10 p.m. Eastern time on
January 6, 2021, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request by telephone call to the staff of the U.S. Securities and Exchange Commission. Please contact Stuart M. Falber of
Wilmer Cutler Pickering Hale and Dorr LLP, counsel to the Company, at (617) 526-6663, or in his absence, Jeffries Oliver-Li at (617)
526-6786, to provide notice of effectiveness, or if you have any other questions regarding this matter.

[Remainder of Page Intentionally Left Blank]

 Very truly yours,

 GENERATION BIO CO.

By:

 /s/ Geoff McDonough

Name: Geoff McDonough, M.D.

Title:   President and Chief Executive Officer

 Signature Page to Acceleration Request